Evidence map›Paper›PMID 25435950›Full record

ArticleOncology letters2015

Rare incidence of primary adrenocortical carcinosarcoma: A case report and literature review.

Yong-Bao Wei, Yun-Liang Gao, Hong-Tao Wu, Shi-Feng Ou-Yang, Tao Xu, Dong-Fang Mao, Jin-Rui Yang

Open access · diamondAbstract read
In one paragraph

Article in Oncology letters, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Yong-Bao WeiDepartment of Urology, The Second Xiangya Hospital, Central South University, Changsha, Hunan 410011, P.R. China.
Yun-Liang GaoDepartment of Urology, The Second Xiangya Hospital, Central South University, Changsha, Hunan 410011, P.R. China.
Hong-Tao WuDepartment of Urology, The Second Xiangya Hospital, Central South University, Changsha, Hunan 410011, P.R. China.
Shi-Feng Ou-YangDepartment of Urology, The Second Xiangya Hospital, Central South University, Changsha, Hunan 410011, P.R. China.
Tao XuDepartment of Urology, The Second Xiangya Hospital, Central South University, Changsha, Hunan 410011, P.R. China.
Dong-Fang MaoDepartment of Urology, The Second Xiangya Hospital, Central South University, Changsha, Hunan 410011, P.R. China.
Jin-Rui YangDepartment of Urology, The Second Xiangya Hospital, Central South University, Changsha, Hunan 410011, P.R. China.
Second Xiangya Hospital of Central South University · CNCentral South University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Adrenocortical carcinoma (ACC) is a rare, but highly aggressive type of tumor with an incidence of one to two per million annually. Adrenocortical carcinosarcoma is an exceptional variant of ACC, which is characterized by the presence of histological regions of carcinoma and sarcoma. To date, to the best of our knowledge, there have only been 12 reported cases of adrenocortical carcinosarcoma. In the present study, a case of primary, non-functional adrenocortical carcinosarcoma is described, as well as a review of the literature to raise awareness of this particularly rare type of malignant neoplasm that is associated with a worse diagnosis and prognosis than adrenocortical carcinoma. In the present study, the patient underwent a laparoscopic left adrenalectomy and the tumor was dissected without complication from the left kidney. Microscopic observations showed the tumor comprised of epithelial and spindle cell components. The patient did not exhibit signs of tumor recurrence at the one-month follow-up. The potential diagnosis of adrenocortical carcinosarcoma must be considered when diagnosing adrenal malignancies in adults. In addition, comphrensive imunohistochemical staining may be required to identify possible sarcomatous patterns. To the best of our knowledge, the present case is the first to report an incidence of adrenocortical carcinosarcoma in China. Details of the patient are presented and the pathology of adrenocortical carcinosarcoma is discussed.

Indexed as

adrenocortical carcinomaadrenocortical carcinosarcomapathology

Identifiers

PMID25435950
PMCPMC4247116
OpenAlexW2062913531

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.